- Canagliflozin Tetra
-
- $0.00 / 25KG
-
2024-11-18
- CAS:866607-35-4
- Min. Order: 1KG
- Purity: 98.0%
- Supply Ability: 10000KGS
|
| D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) Basic information |
Product Name: | D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) | Synonyms: | D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI);(2R,3R,4R,5S,6S)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol tetraacetate;Tetra Acetyl Canagliflozin;D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S);(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate;Canagliflozin impurity 3/Tetra Acetyl Canagliflozin/(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl) thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran- 3,4,5-triyl triacetate;Canagliflozin Tetra | CAS: | 866607-35-4 | MF: | C32H33FO9S | MW: | 612.66 | EINECS: | 617-901-5 | Product Categories: | | Mol File: | 866607-35-4.mol | |
| D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) Chemical Properties |
Melting point | 160-170 °C | Boiling point | 658.3±55.0 °C(Predicted) | density | 1.32±0.1 g/cm3(Predicted) | vapor pressure | 0Pa at 20℃ | solubility | soluble in Chloroform, Ethyl Acetate, Methanol | form | Solid | color | White | LogP | 5.5 at 20℃ |
| D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) Usage And Synthesis |
Uses | The title compound is an intermediate in the synthesis of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. | Flammability and Explosibility | Not classified |
| D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) Preparation Products And Raw materials |
|